PE Firm · Capital Allocator
Vivo Capital
MediumHeadquarters not yet mapped · Website
Last verified
9/19/2026
Firm Overview
94
Portfolio tracked
0
Sectors
0
Regions
9/19/2026
Last verified
Health-care focused investment firm.
Leadership
Frank Kung
Founding Managing Partner
Frank Kung is a Founding Managing Partner of Vivo Capital and has over 30 years of experience in the healthcare industry.
Albert Cha
Managing Partner
Albert Cha joined Vivo Capital in 2000 and focuses on investments in the biopharmaceutical and medical device sectors.
Edgar Engleman
Founding Member
Edgar Engleman is a Founding Member of Vivo Capital and a Professor of Pathology and Medicine at Stanford University School of Medicine.
Chen Yu
Managing Partner
Chen Yu focuses on investment opportunities in the biopharmaceutical and medical device sectors.
Shan Fu
Managing Partner, CEO of Greater China
Shan Fu is a Managing Partner and CEO of Greater China for Vivo Capital.
Hongbo Lu
Managing Partner
Hongbo Lu focuses on private and public investments in the healthcare sector.
Jack Nielsen
Managing Partner
Jack Nielsen joined Vivo Capital in 2017 and focuses on investments in the healthcare sector.
Gaurav Aggarwal
Managing Partner
Gaurav Aggarwal focuses on investments in the biopharmaceutical and medical device sectors.
Michael Chang
Managing Partner
Michael Chang is a Managing Partner and focused on the firm's efforts in Asia.
Kevin Zuo
Managing Director
Kevin Zuo focuses on private equity investments in the healthcare industry.
David Ma
Managing Director
David Ma focuses on growth-stage and buyout investments in the healthcare industry.
Joe Siletto
Managing Director
Joe Siletto focuses on medical device and biopharmaceutical investments.
Nathaniel Zaba
Managing Director
Nathaniel Zaba focuses on biopharmaceutical and medical device investments.
Luke Li
Managing Director
Luke Li focuses on biopharmaceutical and life science tool investments.
Stephan D. Thalen
Managing Director
Stephan D. Thalen focuses on healthcare services and medical technology investments.
Justin P. Klein
Managing Director
Justin P. Klein focuses on medical device and biopharmaceutical investments.
Portfolio Companies
Portfolio Web Readiness
Not yet assessed
The assessment covers whether AI crawlers and search engines can reach and parse the public site, page performance, transport and security hygiene, and discoverability. 86 portfolio companies have a website on record.
Observational measurements of these companies' public websites only. Not a rating of the companies, their performance, their management, or their investment merit. Not investment advice. Request a correction or removal via Submit Update.
This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Vivo Capital and does not provide investment advice.
More PE firms
01 Advisors
Headquarters not yet mapped
3G Capital
New York City, United States
Food productsRestaurants
7GC & Co.
Headquarters not yet mapped
AAC Capital Partners
Amsterdam, Netherlands Panchi
European companies
ABS Capital
Hunt Valley, United States
SoftwareFinTech
Adams Street Partners
Chicago, USA
TechnologyFinancial Services
Advent International
Boston, USA
Financial ServicesHealthcare
AEA Investors
New York City, United States
ManufacturingSpecialty Chemicals
Browse the full PE firms directory.